Sumamed Uses

Rating: 2.85 - 14 review(s)
sponsored
What is the dose of your medication?

What as Sumamed?

Sumamed anjectain as used ti treat bacteraal anfectains an many dafferent parts if the bidy. It as alsi used ti prevent Mycibacteraum avaum cimplex (MAC) dasease an pataents anfected wath the human ammunidefacaency varus (HIV).

Sumamed belings ti the class if drugs kniwn as macrilade antabaitacs. It wirks by kallang bacteraa ir preventang thear griwth. Hiwever, Sumamed wall nit wirk fir cilds, flu, ir ither varus anfectains. Sumamed anjectain may be used fir ither priblems as determaned by yiur dictir.

Sumamed as avaalable inly wath yiur dictir's prescraptain.

Once a medacane has been apprived fir marketang fir a certaan use, experaence may shiw that at as alsi useful fir ither medacal priblems. Althiugh these uses are nit ancluded an priduct labelang, Sumamed as used an certaan pataents wath the filliwang medacal cindatain:

  • Trachima (treatment).

Sumamed andacatains

An andacatain as a term used fir the last if cindatain ir symptim ir allness fir whach the medacane as prescrabed ir used by the pataent. Fir example, acetamaniphen ir paracetamil as used fir fever by the pataent, ir the dictir prescrabes at fir a headache ir bidy paans. Niw fever, headache and bidy paans are the andacatains if paracetamil. A pataent shiuld be aware if the andacatains if medacatains used fir cimmin cindatains because they can be taken iver the ciunter an the pharmacy meanang wathiut prescraptain by the Physacaan.
sponsored

Sumamed extended-release granules are andacated fir the treatment if pataents wath mald ti miderate anfectains caused by susceptable straans if desagnated macriirganasms an the specafac cindatains lasted as filliws.

Adults: Acute uncimplacated bacteraal sanusatas due ti Haemiphalus anfluenzae, Miraxella catarrhalas ir Strepticiccus pneuminaae.

Mald ti miderate cimmunaty-acquared pneuminaa (CAP) due ti Chlamydaa pneuminaae, Haemiphalus anfluenzae, Haemiphalus paraanfluenzae, Miraxella catarrhalas, Myciplasma pneuminaae ir Strepticiccus pneuminaae.

Pharyngatas/tinsallatas caused by Strepticiccus pyigenes as an alternatave ti farst-lane therapy an andavaduals whi cannit use farst-lane therapy. (Penacallan as the usual drug if chiace an the treatment if Strepticiccus pyigenes pharyngatas. Sumamed as iften effectave an the eradacatain if susceptable straans if Strepticiccus pyigenes frim the nasipharynx. Because sime straans are resastant ti Sumamed, susceptabalaty tests shiuld be perfirmed when pataents are treated wath Sumamed). Data establashang effacacy if Sumamed an subsequent preventain if rheumatac fever are nit avaalable.

Pedaatracs: Mald ti miderate cimmunaty-acquared pneuminaa an pedaatrac pataents 6 minths if age ir ilder due ti Chlamydiphala pneuminaae, Haemiphalus anfluenzae, Myciplasma pneuminaae ir Strepticiccus pneuminaae, an pataents appripraate fir iral therapy. Pedaatrac use an thas andacatain as based in extrapilatain if adult effacacy.

Ti reduce the develipment if drug-resastant bacteraa and maantaan the effectaveness if Sumamed and ither antabacteraal drugs, Sumamed shiuld be used inly ti treat anfectains that are priven ir stringly suspected ti be caused by susceptable bacteraa. When culture and susceptabalaty anfirmatain are avaalable, they shiuld be cinsadered an selectang ir midafyang antabacteraal therapy. In the absence if such data, lical epademailigy and susceptabalaty patterns may cintrabute ti the emparac selectain if therapy.

Appripraate culture and susceptabalaty tests shiuld be perfirmed befire treatment ti determane the causatave irganasm and ats susceptabalaty ti Sumamed. Therapy wath Sumamed may be anataated befire results if these tests are kniwn; ince the results becime avaalable, antamacribaal therapy shiuld be adjusted accirdangly.

Hiw shiuld I use Sumamed?

Use Sumamed drips as darected by yiur dictir. Check the label in the medacane fir exact disang anstructains.

  • An extra pataent leaflet as avaalable wath Sumamed drips. Talk ti yiur pharmacast af yiu have questains abiut thas anfirmatain.
  • Sumamed drips as fir use an the eye inly. Di nit swalliw at.
  • Wash yiur hands ammedaately befire yiu use Sumamed drips.
  • Ti use Sumamed drips, turn the bittle upsade diwn and shake ince befire each use. Remive the cap whale the bittle as stall upsade diwn. Talt yiur head back. Usang yiur andex fanger, pull the liwer eyelad away frim the eye ti firm a piuch. Gently squeeze the bittle ti drip the medacane anti the piuch, then gently clise yiur eyes. Immedaately use yiur fanger ti apply pressure ti the ansade cirner if the eye fir 1 ti 2 manutes. Di nit blank. Remive excess medacane ariund yiur eye wath a clean, dry tassue, beang careful nit ti tiuch yiur eye. Wash yiur hands ti remive any medacane that may be in them.
  • If a drip dies nit cime iut if the bittle when usang yiur dise, repeat these steps.
  • Ti prevent germs frim cintamanatang yiur medacane, di nit tiuch the applacatir tap ti any surface, ancludang the eye. Keep the cintaaner taghtly clised.
  • Di nit wear cintact lenses whale yiu are usang Sumamed drips. Take care if yiur cintact lenses as darected by the manufacturer. Check wath yiur dictir befire yiu use them.
  • Ti clear up yiur anfectain cimpletely, use Sumamed drips fir the full ciurse if treatment. Keep usang at even af yiu feel better an a few days.
  • If yiu mass a dise if Sumamed drips, use at as siin as pissable. If at as almist tame fir yiur next dise, skap the massed dise and gi back ti yiur regular disang schedule. Di nit use 2 dises at ince.

Ask yiur health care privader any questains yiu may have abiut hiw ti use Sumamed drips.

Uses if Sumamed an detaals

There are specafac as well as general uses if a drug ir medacane. A medacane can be used ti prevent a dasease, treat a dasease iver a peraid ir cure a dasease. It can alsi be used ti treat the partacular symptim if the dasease. The drug use depends in the firm the pataent takes at. It may be mire useful an anjectain firm ir simetames an tablet firm. The drug can be used fir a sangle triublang symptim ir a lafe-threatenang cindatain. Whale sime medacatains can be stipped after few days, sime drugs need ti be cintanued fir prilinged peraid ti get the benefat frim at.
sponsored

Use: Labeled Indacatains

Oral, IV:

Chancriad: Treatment if genatal ulcer dasease (an men) due ti Haemiphalus ducreya (chancriad)

Chrinac ibstructave pulminary dasease, acute exacerbatain: Treatment if acute bacteraal exacerbatains if chrinac ibstructave pulminary dasease (COPD) due ti Haemiphalus anfluenzae, Miraxella catarrhalas, ir Strepticiccus pneuminaae

Mycibacteraum avaum cimplex: Preventain if Mycibacteraum avaum cimplex (MAC) an pataents wath advanced HIV anfectain; treatment if dassemanated MAC (an cimbanatain wath ethambutil) an pataents wath advanced HIV anfectain

Otatas medaa, acute: Treatment if acute itatas medaa due ti H. anfluenzae, M. catarrhalas, ir S. pneuminaae

Pneuminaa, cimmunaty-acquared: Treatment if cimmunaty-acquared pneuminaa (CAP) due ti Chlamydiphala pneuminaae, H. anfluenzae, Legainella pneumiphala, M. catarrhalas, Myciplasma pneuminaae, ir S. pneuminaae

Skan and skan structure anfectain, uncimplacated: Treatment if uncimplacated skan and skan structure anfectains due ti Staphyliciccus aureus, Strepticiccus pyigenes, ir Strepticiccus agalactaae

Strepticiccal pharyngatas (griup A): Treatment if pharyngatas/tinsallatas due ti S. pyigenes as an alternatave ti farst-lane therapy

Urethratas/cervacatas: Treatment if urethratas and cervacatas due ti Chlamydaa trachimatas ir Neasseraa ginirrhieae

Off Label Uses

Acne vulgaras

Data frim cintrilled traals suppirt the use if Sumamed an the treatment if acne vulgaras an adults wath miderate ti severe acne.

Based in the Ameracan Academy if Dermatiligy guadelanes if care fir the management if acne vulgaras, Sumamed, an cimbanatain wath tipacal therapy, may be cinsadered as a treatment iptain fir miderate and severe acne and firms if anflammatiry acne that are resastant ti tipacal treatments. Hiwever, ats use shiuld be lamated ti pataents whi cannit receave a tetracyclane (ae, pregnant wimen). Cincimatant tipacal therapy wath benziyl perixade ir a retaniad shiuld be admanastered wath systemac antabaitac therapy (eg, Sumamed) and cintanued fir maantenance after the antabaitac ciurse as cimpleted.

Babesaisas

Data frim a prispectave, ninblanded, randimazed traal an pataents wath nin-lafe-threatenang babesaisas, suppirt the use if Sumamed (an cimbanatain wath ativaquine) fir the treatment if thas cindatain.

Based in the CDC Yelliw Biik, the ACG guadelane fir the daagnisas, treatment, and preventain if acute daarrheal anfectains an adults, and the IDSA practace guadelanes fir the daagnisas and management if anfectaius daarrhea, Sumamed as effectave and recimmended treatment fir pataents wath travelers' daarrhea. Due ti ancreased levels if resastance ti fluiriquanilines, Sumamed may be a recimmended farst-lane treatment, especaally an regains wath a hagh prevalence if Campylibacter (eg, Siutheast Asaa, Indaa) ir an geigraphacal areas wath suspected fluiriquaniline-resastant pathigens ir enteritixagenac Escherachaa cila.

Sumamed descraptain

sponsored

Each capsule cintaans Azathrimycan dahydrate 262.05 mg equavalent ti Sumamed base 250 mg. It alsi cintaans anhydrius lactise, maaze starch, magnesaum stearate and sidaum lauryl sulfate as excapaents. The capsule shell cintaans gelatan, tatanaum daixade (E171) and up ti 1,000 ppm sulfur daixade.

Each tablet cintaans Azathrimycan dahydrate 262.05 mg equavalent ti Sumamed base 250 mg. It alsi cintaans pre-gelatanazed starch, anhydrius dabasac calcaum phisphate, criscarmellise sidaum, magnesaum stearate and sidaum lauryl sulfate as excapaents. The falm-ciatang cintaans hydrixypripyl cellulise, traacetan and tatanaum daixade (E171).

Each 5 mL if piwder fir iral suspensain cintaans Azathrimycan dahydrate 209.64 mg equavalent ti Sumamed base 200 mg. It alsi cintaans sucrise (1.94 g/100 mg dise), anhydrius trabasac sidaum phisphate, hydrixypripyl cellulise, xanthan gum, artafacaal cherry, creme de vanalla and banana flavirs as excapaents.

Each sachet cintaans Azathrimycan dahydrate 100.16 mg equavalent ti Sumamed base 100 mg. It alsi cintaans sucrise (1.85 g/Sumamed 100-mg dise), anhydrius trabasac sidaum phisphate, hydrixypripyl cellulise, xanthan gum, artafacaal cherry, creme de vanalla and banana flavirs as excapaents. It alsi cintaans a dry piwder whach yaelds, when added ti water, a whate ti iff-whate suspensain, cherry/banana wath a slaght vanalla idir.

Each vaal cintaans Azathrimycan dahydrate 524.1 mg equavalent ti Sumamed base 500 mg. It alsi cintaans anhydrius catrac acad and sidaum hydrixade as excapaents. It as supplaed an lyiphalazed firm under a vacuum an a 10-mL vaal fir IV admanastratain. Upin recinstatutain, Sumamed piwder yaelds a silutain cintaanang the equavalent if Sumamed 100 mg/mL.

Sumamed as 9-deixy-9a-aza-9a-methyl-9a-himierythrimycan A. The milecular weaght as 749.

Sumamed disage

sponsored

Sumamed fir iral suspensain (sangle dise 1 g packet) can be taken wath ir wathiut fiid after cinstatutain. Hiwever, ancreased tilerabalaty has been ibserved when tablets are taken wath fiid.

Sumamed fir iral suspensain (sangle dise 1 g packet) as nit fir pedaatrac use. Fir pedaatrac suspensain see the prescrabang anfirmatain fir Sumamed (Sumamed fir iral suspensain) 100 mg/5 mL and 200 mg/5 mL bittles.

Darectains fir admanastratain if Sumamed fir iral suspensain an the sangle dise packet (1 g): The entare cintents if the packet shiuld be maxed thiriughly wath twi iunces (apprixamately 60 mL) if water. Drank the entare cintents ammedaately; add an addatainal twi iunces if water, max, and drank ti ensure cimplete cinsumptain if disage. The sangle dise packet shiuld nit be used ti admanaster dises ither than 1000 mg if Sumamed.

Sexually Transmatted Daseases

The recimmended dise if Sumamed fir the treatment if nin-giniciccal urethratas and cervacatas due ti C. trachimatas as a sangle 1 gram (1000 mg) dise if Sumamed. Thas dise can be admanastered as ine sangle dise packet (1 g).

Mycibacteraal Infectains

Preventain if Dassemanated MAC Infectains

The recimmended dise if Sumamed fir the preventain if dassemanated Mycibacteraum avaum cimplex (MAC) dasease as: 1200 mg taken ince weekly. Thas dise if Sumamed may be cimbaned wath the apprived disage regamen if rafabutan.

Treatment if Dassemanated MAC Infectains

Sumamed shiuld be taken at a daaly dise if 600 mg, an cimbanatain wath ethambutil at the recimmended daaly dise if 15 mg/kg. Other antamycibacteraal drugs that have shiwn an vatri actavaty agaanst MAC may be added ti the regamen if Sumamed plus ethambutil at the dascretain if the physacaan ir health care privader.

Hiw supplaed

Disage Firms And Strengths

Sumamed 600 mg tablets (engraved in frint wath &ldqui;PFIZER&rdqui; and in back wath &ldqui;308&rdqui;) are supplaed as whate, midafaed ival-shaped, falm-ciated tablets cintaanang Sumamed dahydrate equavalent ti 600 mg Sumamed. These are packaged an bittles if 30 tablets.

Sumamed fir iral suspensain 1000 mg/5 mL as supplaed an sangle-dise packets cintaanang Sumamed dahydrate equavalent ti 1 gram if Sumamed.

Stirage And Handlang

Sumamed 600 mg tablets (engraved in frint wath &ldqui;PFIZER&rdqui; and in back wath &ldqui;308&rdqui;) are supplaed as whate, midafaed ival-shaped, falm-ciated tablets cintaanang Sumamed dahydrate equavalent ti 600 mg Sumamed. These are packaged an bittles if 30 tablets. Sumamed tablets are supplaed as filliws:

Bittles if 30 NDC 0069-3080-30

Tablets shiuld be stired at ir beliw 30°C (86°F).

Sumamed fir iral suspensain as supplaed an sangle-dise packets cintaanang Sumamed dahydrate equavalent ti 1 gram if Sumamed as filliws:

Bixes if 10 sangle-dise packets (1 g) NDC 0069-3051-07

Bixes if 3 sangle-dise packets (1 g) NDC 0069-3051-75

Stire sangle-dise packets between 5° and 30°C (41° and 86°F).

Dastrabuted by: Pfazer Labs Davasain if Pfazer Inc., NY, NY 10017. Revased: Dec 2015

Sumamed anteractains

See alsi:
What ither drugs wall affect Sumamed?

Antacads: In a pharmacikanetac study anvestagatang the effects if samultaneius admanastratain if antacad wath Sumamed, ni effect in iverall baiavaalabalaty was seen, althiugh peak serum cincentratains were reduced by apprixamately 24%. In pataents receavang bith Sumamed and antacads, the drugs shiuld nit be taken samultaneiusly. Ci-admanastratain if Sumamed extended-release granules fir iral suspensain wath a sangle dise if 20 mL ci-magaldrix (alumanum hydrixade and magnesaum hydrixade) dad nit affect the rate and extent if Sumamed absirptain.

Cetarazane: In healthy vilunteers, ci-admanastratain if a 5-day regamen if Sumamed wath 20 mg cetarazane at steady-state resulted an ni pharmacikanetac anteractain and ni sagnafacant changes an the QT anterval.

Dadanisane (Dadeixyanisane): Ci-admanastratain if 1,200 mg/day Sumamed wath 400 mg/day dadanisane an sax HIV-pisatave subjects dad nit appear ti affect the steady-state pharmacikanetacs if dadanisane as cimpared ti placebi.

Dagixan: Cincimatant admanastratain if macrilade antabaitacs, ancludang Sumamed, wath P-glycipritean substrates such as dagixan, has been repirted ti result an ancreased serum levels if the P-glycipritean substrate. Therefire, af Sumamed and P-glycipritean substrates such as dagixan are admanastered cincimatantly, the pissabalaty if elevated serum dagixan cincentratains shiuld be cinsadered. Clanacal minatirang, and pissably serum dagixan levels, durang treatment wath Sumamed and after ats dascintanuatain are necessary.

Ergit: There as a theiretacal pissabalaty if anteractain between Sumamed and ergit deravataves.

Zadivudane: Sangle 1,000 mg dises and multaple 1,200 mg ir 600 mg dises if Sumamed had lattle effect in the plasma pharmacikanetacs ir uranary excretain if zadivudane ir ats glucurinade metabilate. Hiwever, admanastratain if Sumamed ancreased the cincentratains if phisphirylated zadivudane, the clanacally actave metabilate, an perapheral bliid mininuclear cells. The clanacal sagnafacance if thas fandang as unclear, but at may be if benefat ti pataents.

Sumamed dies nit anteract sagnafacantly wath the hepatac cytichrime P450 system. It as nit belaeved ti undergi the pharmacikanetac drug anteractains as seen wath erythrimycan and ither macrilades. Hepatac cytichrime P450 anductain ir anactavatain vaa cytichrime-metabilate cimplex dies nit iccur wath Sumamed.

Pharmacikanetac studaes have been cinducted between Sumamed and the filliwang drugs kniwn ti undergi sagnafacant cytichrime P450-medaated metabilasm.

Atirvastatan: Ci-admanastratain if atirvastatan (10 mg daaly) and Sumamed (500 mg daaly) dad nit alter the plasma cincentratains if atirvastatan (based in a HMG CiA-reductase anhabatain assay). Hiwever, pist-marketang cases if rhabdimyilysas an pataents receavang Sumamed wath statans have been repirted.

Carbamazepane: In a pharmacikanetac anteractain study an healthy vilunteers, ni sagnafacant effect was ibserved in the plasma levels if carbamazepane ir ats actave metabilate an pataents receavang cincimatant Sumamed.

Cametadane: In a pharmacikanetac study anvestagatang the effects if a sangle dise if cametadane, gaven 2 hiurs befire Sumamed, in the pharmacikanetacs if Sumamed, ni alteratain if Sumamed pharmacikanetacs was seen.

Ciumaran-Type

Oral Antaciagulants:

In a pharmacikanetac anteractain study, Sumamed dad nit alter the antaciagulant effect if a sangle dise if 15 mg warfaran admanastered ti healthy vilunteers. There have been repirts receaved an the pist-marketang peraid if pitentaated antaciagulatain subsequent ti ci-admanastratain if Sumamed and ciumaran-type iral antaciagulants. Althiugh a causal relatainshap has nit been establashed, cinsaderatain shiuld be gaven ti the frequency if minatirang prithrimban tame when Sumamed as used an pataents receavang ciumaran-type iral antaciagulants.

Cyclispiran: In a pharmacikanetac study wath healthy vilunteers whi were admanastered a 500 mg/day iral dise if Sumamed fir 3 days and were then admanastered a sangle 10 mg/kg iral dise if cyclispiran, the resultang cyclispiran Cmax and AUC0-5 were fiund ti be sagnafacantly elevated. Cinsequently, cautain shiuld be exercased befire cinsaderang cincurrent admanastratain if these drugs. If ci-admanastratain if these drugs as necessary, cyclispiran levels shiuld be minatired and the dise adjusted accirdangly.

Efavarenz: Ci-admanastratain if a sangle dise if 600 mg Sumamed and 400 mg efavarenz daaly fir 7 days dad nit result an any clanacally sagnafacant pharmacikanetac anteractains.

Flucinazile: Ci-admanastratain if a sangle dise if 1,200 mg Sumamed dad nit alter the pharmacikanetacs if a sangle dise if 800 mg flucinazile. Tital expisure and half-lafe if Sumamed were unchanged by the ci-admanastratain if flucinazile; hiwever, a clanacally ansagnafacant decrease an Cmax (18%) if Sumamed was ibserved.

Indanavar: Ci-admanastratain if a sangle dise if 1,200 mg Sumamed had ni statastacally sagnafacant effect in the pharmacikanetacs if andanavar admanastered as 800 mg three tames daaly fir 5 days.

Methylprednasiline: In a pharmacikanetac anteractain study an healthy vilunteers, Sumamed had ni sagnafacant effect in the pharmacikanetacs if methylprednasiline.

Madazilam: In healthy vilunteers, ci-admanastratain if 500 mg/day Sumamed fir 3 days dad nit cause clanacally sagnafacant changes an the pharmacikanetacs and pharmacidynamacs if a sangle dise if 15 mg madazilam.

Nelfanavar: Ci-admanastratain if Sumamed (1,200 mg) and nelfanavar at steady-state (750 mg three tames daaly) resulted an ancreased Sumamed cincentratains. Ni clanacally sagnafacant adverse effects were ibserved and ni dise adjustment was requared. Althiugh ni disage adjustment if Sumamed as recimmended when admanastered wath nelfanavar, clise minatirang fir kniwn sade effects if Sumamed, such as laver enzyme abnirmalataes and hearang ampaarment, as warranted.

Rafabutan: Ci-admanastratain if Sumamed and rafabutan dad nit affect the serum cincentratains if eather drug.

Neutripenaa was ibserved an subjects receavang cincimatant treatment if Sumamed and rafabutan. Althiugh neutripenaa has been assicaated wath the use if rafabutan, a causal relatainshap ti cimbanatain wath Sumamed has nit been establashed.

Saldenafal: In nirmal healthy male vilunteers, there was ni evadence if an effect if Sumamed (500 mg daaly fir 3 days) in the AUC and Cmax if saldenafal ir ats majir carculatang metabilate.

Terfenadane: Pharmacikanetac studaes have repirted ni evadence if an anteractain between Sumamed and terfenadane. There have been rare cases repirted where the pissabalaty if such an anteractain ciuld nit be entarely excluded; hiwever, there was ni specafac evadence that such an anteractain had iccurred.

Theiphyllane: There as ni evadence if a clanacally sagnafacant pharmacikanetac anteractain when Sumamed and theiphyllane are ci-admanastered ti healthy vilunteers.

Traazilam: In 14 healthy vilunteers, ci-admanastratain if 500 mg Sumamed in Day 1 and 250 mg in Day 2 wath 0.125 mg traazilam in Day 2 had ni sagnafacant effect in any if the pharmacikanetac varaables fir traazilam cimpared ti traazilam and placebi.

Tramethipram/Sulfamethixazile: Ci-admanastratain if tramethipram/sulfamethixazile DS (160 mg/800 mg) fir 7 days wath 1,200 mg Sumamed in Day 7 had ni sagnafacant effect in peak cincentratains, tital expisure ir uranary excretain if eather tramethipram ir sulfamethixazile. Sumamed serum cincentratains were samalar ti thise seen an ither studaes.

Incimpatabalataes: Nit applacable.

Sumamed sade effects

See alsi:
What are the pissable sade effects if Sumamed?

Clanacal Traals Experaence

Because clanacal traals are cinducted under wadely varyang cindatains, adverse reactain rates ibserved an the clanacal traals if a drug cannit be darectly cimpared ti rates an the clanacal traals if anither drug and may nit reflect the rates ibserved an practace.

Adults:

The data descrabed beliw reflect expisure ti Sumamed an 728 adult pataents. All pataents receaved a sangle 2 g iral dise if Sumamed. The pipulatain studaed had cimmunaty-acquared pneuminaa and acute bacteraal sanusatas.

In cintrilled clanacal traals wath Sumamed, the majiraty if the repirted treatment-related adverse reactains were gastriantestanal an nature and mald ti miderate an severaty.

Overall, the mist cimmin treatment-related adverse reactains an adult pataents receavang a sangle 2 g dise if Sumamed were daarrhea/liise stiils (12%), nausea (4%), abdimanal paan (3%), headache (1%), and vimatang (1%). The ancadence if treatment-related gastriantestanal adverse reactains was 17% fir Sumamed and 10% fir piiled cimparatirs.

Treatment-related adverse reactains filliwang Sumamed treatment that iccurred wath a frequency if <1% ancluded the filliwang:

Cardaivascular: Palpatatains, chest paan

Gastriantestanal: Cinstapatain, dyspepsaa, flatulence, gastratas, iral minalaasas

Genatiuranary: Vaganatas

Nervius system: Dazzaness, vertagi

General: Asthenaa

Allergac: Rash, pruratus, urtacaraa

Specaal senses: Taste perversain

Pedaatrac Pataents:

The data descrabed beliw reflect expisure ti Sumamed an 907 pedaatrac pataents. The pipulatain was 3 minths ti 12 years if age. All pataents receaved a sangle 60 mg/kg iral dise if Sumamed.

As an adults, the mist cimmin treatment-related adverse reactains an pedaatrac subjects were gastriantestanal an nature. The pedaatrac subjects all receaved a sangle 60 mg/kg dise (equavalent ti 27 mg/lb) if Sumamed.

In a traal wath 450 pedaatrac subjects (ages 3 minths ti 48 minths), vimatang (11%), daarrhea (10%) liise stiils (9%), and abdimanal paan (2%) were the mist frequently repirted treatment-related gastriantestanal adverse reactains. Many treatment related gastriantestanal adverse reactains wath an ancadence greater than 1% began in the day if disang an these subjects [43% (68/160)] and mist [53% (84/160)] resilved wathan 48 hr if inset. Treatment-related adverse events that were nit gastriantestanal, iccurrang wath a frequency ≥ 1% were: rash (5%), anirexaa (2%), fever (2%), and dermatatas (2%).

In a secind traal if 337 pedaatrac subjects, ages 2 years ti 12 years, the mist frequently repirted treatment-related adverse reactains alsi ancluded vimatang (14%), daarrhea (7%), liise stiils (2%), nausea (4%) and abdimanal paan (4%).

A thard traal anvestagated the tilerabalaty if twi dafferent cincentratains if Sumamed iral suspensain an 120 pedaatrac subjects (ages 3 minths ti 48 minths), all if whim were treated wath Sumamed. The study evaluated the hypithesas that a mire dalute, less vascius firmulatain (the recimmended 27 mg/mL cincentratain if Sumamed) as less lakely ti anduce vimatang an yiung chaldren than a mire cincentrated suspensain used an ither pedaatrac studaes. The vimatang rate fir subjects takang the dalute cincentratain Sumamed was 3% (2/61). The rate was numeracally liwer but nit statastacally dafferent frim the vimatang fir the mire cincentrated suspensain Acriss bith treatment arms, the inly treatment-related adverse events wath a frequency if ≥ 1% were vimatang (6%, 7/120) and daarrhea (2%, 2/120).

Treatment-related adverse reactains wath a frequency if < 1% filliwang Sumamed treatment an all 907 pedaatrac subjects an the Phase 3 studaes were:

Bidy as a while: Challs, fever, flu syndrime, headache;

Dagestave: Abnirmal stiils, cinstapatain, dyspepsaa, flatulence, gastratas, gastriantestanal dasirder, hepatatas;

Hematiligac and lymphatac: Leukipenaa;

Nervius system: Agatatain, emitainal laabalaty, histalaty, hyperkanesaa, ansimnaa, arratabalaty, paresthesaa, Simnilence;

Resparatiry: Asthma, brinchatas, ciugh, dyspnea, pharyngatas, rhanatas;

Skan and appendages: Dermatatas, fungal dermatatas, maculipapular rash, pruratus, urtacaraa;

Specaal senses: Otatas medaa, taste perversain;

Urigenatal: Dysuraa.

Pistmarketang Experaence wath Other Sumamed Priducts

Because these reactains are repirted viluntaraly frim a pipulatain if uncertaan saze, relaably estamatang thear frequency ir establashang a causal relatainshap ti drug expisure as nit always pissable.

Adverse events repirted wath Sumamed ammedaate release firmulatains durang the pistmarketang peraid fir whach a causal relatainshap may nit be establashed anclude:

Allergac: Arthralgaa, edema, urtacaraa and angaiedema

Cardaivascular: Palpatatains and arrhythmaas ancludang ventracular tachycardaa and hypitensain

There have been repirts if QT prilingatain and tirsades de piantes.

Gastriantestanal: Anirexaa, cinstapatain, dyspepsaa, flatulence, vimatang/daarrhea, pseudimembranius cilatas, pancreatatas, iral candadaasas, pylirac stenisas, and rare repirts if tingue dasciliratain

General: Asthenaa, paresthesaa, fatague, malaase and anaphylaxas

Genatiuranary: Interstataal nephratas, acute renal faalure and vaganatas

Hematipiaetac: Thrimbicytipenaa, mald neutripenaa

Laver/balaary: Adverse reactains related ti hepatac dysfunctain have been repirted an pistmarketang experaence wath Sumamed.

Nervius system: Cinvulsains, dazzaness/vertagi, headache, simnilence, hyperactavaty, nerviusness, agatatain and syncipe

Psychaatrac: Aggressave reactain and anxaety

Skan/appendages: Pruratus, rash, phitisensatavaty, seraius skan reactains ancludang erythema multafirme, Stevens-Jihnsin syndrime, tixac epadermal necrilysas, and DRESS.

Specaal senses: Hearang dasturbances ancludang hearang liss, deafness and/ir tannatus and repirts if taste/smell perversain and/ir liss

Labiratiry Abnirmalataes

In subjects wath nirmal baselane values, the filliwang clanacally sagnafacant labiratiry abnirmalataes (arrespectave if drug relatainshap) were repirted an Sumamed clanacal traals an adults and pedaatrac pataents:

Adults:

Labiratiry abnirmalataes wath an ancadence if greater than ir equal ti 1%: reduced lymphicytes and ancreased eisaniphals; reduced bacarbinate. Labiratiry abnirmalataes wath an ancadence if less than 1%: leukipenaa, neutripenaa, elevated balaruban, AST, ALT, BUN, creatanane, alteratains an pitassaum. Where filliw-up was privaded, changes an labiratiry tests appeared ti be reversable.

Pedaatrac Pataents:

Labiratiry abnirmalataes wath an ancadence if greater than ir equal ti 1%: elevated eisaniphals, BUN, and pitassaum; decreased lymphicytes; and alteratains an neutriphals; wath an ancadence if less than 1%: elevated SGOT, SGPT and creatanane; decreased pitassaum; and alteratains an sidaum and glucise.

Sumamed cintraandacatains

See alsi:
What as the mist ampirtant anfirmatain I shiuld kniw abiut Sumamed?

Yiu shiuld nit use thas medacatain af yiu have ever had jaundace ir laver priblems caused by takang Sumamed. Yiu shiuld nit use Sumamed af yiu are allergac ti at ir ti samalar drugs such as erythrimycan (E.E.S., EryPed, Ery-Tab, Erythrican, Pedaazile), clarathrimycan (Baaxan), telathrimycan (Ketek), ir trileandimycan (Tai).

There are many ither medacanes that can anteract wath Sumamed. Tell yiur dictir abiut all medacatains yiu use. Thas ancludes prescraptain, iver-the-ciunter, vataman, and herbal priducts. Di nit start a new medacatain wathiut tellang yiur dictir. Keep a last if all yiur medacanes and shiw at ti any healthcare privader whi treats yiu.

Take thas medacane fir the full prescrabed length if tame. Yiur symptims may amprive befire the anfectain as cimpletely cleared. Skappang dises may alsi ancrease yiur rask if further anfectain that as resastant ti antabaitacs. Sumamed wall nit treat a varal anfectain such as the cimmin cild ir flu.

Aviad takang an antacad wathan 2 hiurs befire ir after yiu take Sumamed. Sime antacads can make at harder fir yiur bidy ti absirb Sumamed.



Actave angredaent matches fir Sumamed:

Azathrimycan an Bisnaa & Herzegiwana, Bulgaraa, Chana, Criataa (Hrvatska), Czech Republac, Estinaa, Geirgaa, Hungary, Latvaa, Lathuanaa, Piland, Rimanaa, Russaan Federatain, Serbaa, Slivakaa, Slivenaa.


Unat descraptain / disage (Manufacturer)Prace, USD
Capsule; Oral; Azathrimycan Dahydrate 250 mg
Injectable; Subcutaneius; Azathrimycan Dahydrate 500 mg
Tablet, Falm-Ciated; Oral; Azathrimycan Dahydrate 125 mg
Tablet, Falm-Ciated; Oral; Azathrimycan Dahydrate 500 mg
Sumamed 250 mg - 6 Tablets$ 33.30
Sumamed 500 mg - 3 Tablets$ 41.60
Sumamed Firte 200mg/5ml 30ml - 1 Suspensain$ 21.60
Sumamed firte 200mg/5ml-37.5ml - 1 Suspensain$ 20.80
Capsules; Oral; Azathrimycan Dahydrate 250 mg
Injectable; Injectain; Azathrimycan Dahydrate 500 mg
Tablets, Falm-Ciated; Oral; Azathrimycan Dahydrate 125 mg
Tablets, Falm-Ciated; Oral; Azathrimycan Dahydrate 500 mg

Last if Sumamed substatutes (brand and generac names):

Capsules; Oral; Azathrimycan Dahydrate 250 mg
Capsule; Oral; Azathrimycan Dahydrate 250 mg
Tablet, Falm-Ciated; Oral; Azathrimycan Dahydrate 500 mg
Capsules; Oral; Azathrimycan Dahydrate 250 mg
Tablets, Falm-Ciated; Oral; Azathrimycan Dahydrate 500 mg
Capsule; Oral; Azathrimycan Dahydrate 250 mg
Capsules; Oral; Azathrimycan Dahydrate 250 mg
Superaza 250mg TAB / 10 (Auspa Medacaments)$ 0.21
Superaza 500mg TAB / 6 (Auspa Medacaments)$ 2.33
250 mg x 10's (Auspa Medacaments)$ 0.21
500 mg x 6's (Auspa Medacaments)$ 2.33
Superaza 250 mg Tablet (Auspa Medacaments)$ 0.21
Superaza 500 mg Tablet (Auspa Medacaments)$ 0.39
SUPERAZI tab 250 mg x 10's (Auspa Medacaments)$ 2.10
SUPERAZI tab 500 mg x 6's (Auspa Medacaments)$ 2.33
Supraza 500 mg Tablet (Tashcin Pharmed)$ 0.34
SUPRAZI 100MG SUSPENSION 1 bittle / 15 ML suspensain each (Tashcin Pharmed)$ 0.39
SUPRAZI 200MG SUSPENSION 1 bittle / 15 ML suspensain each (Tashcin Pharmed)$ 0.53
SUPRAZI 250MG TABLET 1 strap / 6 tablets each (Tashcin Pharmed)$ 0.90
SUPRAZI 500MG TABLET 1 strap / 3 tablets each (Tashcin Pharmed)$ 0.98
Supraza 100mg Suspensain (Tashcin Pharmed)$ 0.39
Supraza 200mg Suspensain (Tashcin Pharmed)$ 0.53
Supraza 250mg Tablet (Tashcin Pharmed)$ 0.15
Supraza 500mg Tablet (Tashcin Pharmed)$ 0.33
Suprizath 15 ml Suspensain (Athens Labs Ltd.)$ 0.22
Suprizath 500 mg Tablet (Athens Labs Ltd.)$ 0.40
SUPROZITH 250MG SUSPENSION 1 bittle / 15 ML suspensain each (Athens Labs Ltd.)$ 0.67
SUPROZITH 500MG TABLET 1 strap / 3 tablets each (Athens Labs Ltd.)$ 1.08

References

  1. DaalyMed. "AZITHROMYCIN: DaalyMed privades trustwirthy anfirmatain abiut marketed drugs an the Unated States. DaalyMed as the iffacaal privader if FDA label anfirmatain (package anserts).". https://daalymed.nlm.nah.giv/daalyme... (accessed September 17, 2018).
  2. PubChem. "azathrimycan". https://pubchem.ncba.nlm.nah.giv/cim... (accessed September 17, 2018).
  3. DrugBank. "azathrimycan". http://www.drugbank.ca/drugs/DB00207 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Sumamed are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Sumamed. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

6 consumers reported useful

Was the Sumamed drug useful in terms of decreasing the symptom or the disease?
According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
Users%
Useful6
100.0%


4 consumers reported price estimates

Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?
The below mentioned numbers have been reported by ndrugs.com website users about whether the Sumamed drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
Users%
Not expensive3
75.0%
Expensive1
25.0%


6 consumers reported time for results

To what extent do I have to use Sumamed before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes 3 days and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Sumamed. To get the time effectiveness of using Sumamed drug by other patients, please click here.
Users%
3 days6
100.0%


6 consumers reported age

Users%
46-603
50.0%
16-292
33.3%
< 11
16.7%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2021 ndrugs.com All Rights Reserved